TechnologyStill being tested

Oracle (ORCL)

Foghorn reads the news on Oracle and calls up or down only when a story is strong enough to move the stock, so most days there's no call. Every call is locked before the market reacts and graded here once its time is up.

Last close $130.68 on Fri, Oct 30 (IEX)

Calls for the next trading day0 of 1right, 0% of 1 call where the stock moved
Calls for the next 5 trading days1 of 1right, 100% of 1 call where the stock moved

Graded calls on ORCL

Most recently judged first. Calls appear here once they're graded, and once every other call on the same news is graded too.
  • Judged Oct 28ORCLOracleCalled Up · next 5 dayshow sure: about 6 in 10The news: Recon: AZ, Oracle partner for AI-powered clinical trials; FDA approves Haemonetics vascular closure systemThe stock rose 11.8%Result: RightLocked Oct 20, 6:02 PM ET , before its first judged close
    Fingerprint 2f0794…4e607f062f0794989cf1121f5600efbae1a7569ce6463ffbeda5e7e82345b82e4e607f06
  • Judged Oct 22ORCLOracleCalled Up · next dayhow sure: a bit better than evenThe news: Recon: AZ, Oracle partner for AI-powered clinical trials; FDA approves Haemonetics vascular closure systemThe stock fell 2.8%Result: WrongLocked Oct 20, 6:02 PM ET , before its first judged close
    Fingerprint fcd0cc…1deecb48fcd0cc837aee946ab279effa1320885abb35d647bda9c25ba62aa6401deecb48

General market commentary, made the same way for everyone. It isn't investment advice or a recommendation to buy or sell ORCL, and past accuracy does not promise future results.